The DOI matches its Crossref record; 96 of the 98 references it cites were found in a registry or an index; none of the 33 sources its claims cite is checked for support yet.
Codon optimization is an essential parameter for the efficient allotopic expression of mtDNA genes
Open accessAbstract
Mutations in mitochondrial DNA can be inherited or occur de novo leading to several debilitating myopathies with no curative option and few or no effective treatments. Allotopic expression of recoded mitochondrial genes from the nucleus has potential as a gene therapy strategy for such conditions, however progress in this field has been hampered by technical challenges. Here we employed codon optimization as a tool to re-engineer the protein-coding genes of the human mitochondrial genome for robust, efficient expression from the nucleus. All 13 codon-optimized constructs exhibited substantially higher protein expression than minimally-recoded genes when expressed transiently, and steady-state mRNA levels for optimized gene constructs were 5-180 fold enriched over recoded versions in stably-selected wildtype cells. Eight of thirteen mitochondria-encoded oxidative phosphorylation (OxPhos) proteins maintained protein expression following stable selection, with mitochondrial localization of expression products. We also assessed the utility of this strategy in rescuing mitochondrial disease cell models and found the rescue capacity of allotopic expression constructs to be gene specific. Allotopic expression of codon optimized ATP8 in disease models could restore protein levels and respiratory function, however, rescue of the pathogenic phenotype for another gene, ND1 was only partially successful. These results imply that though codon-optimization alone is not sufficient for functional allotopic expression of most mitochondrial genes, it is an essential consideration in their design.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Codon optimization of all 13 human mtDNA protein-coding genes for nuclear expression produced substantially higher transient protein expression than minimally recoded versions and enabled stable protein expression for 8 of 13 genes. In disease models, codon-optimized ATP8 restored protein levels and respiratory function, whereas codon-optimized ND1 only partially rescued the mutant phenotype, indicating codon optimization is necessary but often not sufficient for functional allotopic expression.
Key findings
- All 13 codon-optimized constructs showed substantially higher transient protein expression than minimally recoded genes in HEK293 cells; only 3 of 13 minimally recoded genes (rND3, rCOX1, rATP8) produced detectable mitochondrial protein transiently.
- In stably selected wild-type cells, steady-state mRNA levels for optimized constructs were 5–180 fold enriched over recoded versions; 8 of 13 optimized OxPhos proteins maintained stable protein expression (oND1, oND2, oND3, oND4, oND4L, oND6, oCOX2, oATP8), while only rND4 showed appreciable stable protein among recoded genes.
- In ND1m (m.3751insC) cells, oND1 mRNA was ~210-fold higher than rND1; FLAG-tagged oND1 incorporated into Complex I and restored some in-gel CI activity, but ND1m cells grew at ~25% of wild-type rate in glucose, and FLAG-oND1 expression gave only modest galactose survival improvement (18% average total viability, 32% of wild-type galactose viability).
- In A8/A6mut cells, oATP8 mRNA was ~28-fold higher than rATP8 and only codon-optimized ATP8 produced stable protein; in C57/BL6(mtFVB) mouse fibroblasts, optimized mouse Atp8 integrated into Complex V and mutant cells expressing it grew significantly better than non-complemented cells in glucose or galactose.
Methods
- The authors synthesized minimally recoded (r) and codon-optimized (o) versions of all 13 human mtDNA protein-coding genes, plus mouse mt-Atp8, each with an N-terminal ATP5G1 MTS and C-terminal FLAG tag, and expressed them transiently or stably in HEK293 cells, patient-derived cybrids (ND1m and A8/A6mut), and C57/BL6(mtFVB) mouse fibroblasts.
- Protein expression and mitochondrial localization were assessed by SDS-PAGE and Blue Native PAGE immunoblotting; Complex I in-gel activity, competitive growth in glucose versus galactose, and RT-qPCR normalized to COX10 or GAPDH were used to measure function and mRNA levels.
- Codon usage was analyzed by relative synonymous codon usage (RSCU) using nuclear genome codon frequencies; statistical comparisons used unpaired Student’s t-tests, one-way ANOVA with Dunnett’s test, and P < 0.05 significance.
Limitations
- The paper states that the ND1 cybrid model is artificial and the ND1 null mutation is prone to reverting to heteroplasmy under prolonged culture, complicating functional rescue interpretation.
- The paper states that MTS cleavage was incomplete for several allotopically expressed proteins, that only a fraction of expressed protein functionally integrates, and that codon optimization alone is not sufficient for functional allotopic expression of most mitochondrial genes.
- Evident from the text: the minimally recoded ND6 construct repeatedly failed synthesis, so no paired rND6 comparison was possible; some optimized genes (oND5, oCYB, oCOX1, oCOX3, oATP6) failed to maintain stable protein expression; and the mouse viability experiment in Fig. 6D used n=2 biological replicates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 33 cited sources checked · 0 supported · 0 flagged
- Findingown data
Steady-state mRNA levels for optimized gene constructs were 5-180 fold enriched over recoded versions in stably-selected wildtype cells.
“steady-state mRNA levels for optimized gene constructs were 5–180 fold enriched over recoded versions in stably-selected wildtype cells”
Quote in the paperSubstantial claim - Findingown data
All 13 codon-optimized constructs exhibited substantially higher protein expression than minimally-recoded genes when expressed transiently.
“All 13 codon-optimized constructs exhibited substantially higher protein expression than minimally-recoded genes when expressed transiently”
Quote in the paperSubstantial claim - Findingown data
Allotopic expression of codon optimized ATP8 in disease models could restore protein levels and respiratory function.
“Allotopic expression of codon optimized ATP8 in disease models could restore protein levels and respiratory function”
Quote in the paperSubstantial claim - Findingown data
Rescue of the pathogenic phenotype for ND1 was only partially successful.
“rescue of the pathogenic phenotype for another gene, ND1 was only partially successful”
Quote in the paperSubstantial claim - Findingown data
Under stable expression, ATP8 protein was detectable only with the codon-optimized version.
“while stable expression was detectable only with the optimized version (Fig. 3C).”
Quote in the paperSubstantial claim
- Findingown data
In transiently transfected HEK293 cells, all 13 codon-optimized mitochondrial genes resulted in exogenous mitochondrially-enriched proteins as judged by SDS-PAGE.
“all 13 codon-optimized genes resulted in exogenous mitochondrially-enriched proteins as judged by SDS-PAGE”
Quote in the paperSubstantial claim - Findingown data
Mutants expressing FLAG-tagged oND1 demonstrated a modest but statistically significant improvement in galactose survival, with an 18% average total viability, corresponding to 32% of wild-type viability in galactose.
“Mutants expressing FLAG-tagged oND1, however, did demonstrate a modest, but statistically significant improvement in galactose survival, with an 18% average total viability, corresponding to 32% of wild-type viability in galactose”
Quote in the paperSubstantial claim - Findingown data
Levels of allotopic gene expression and protein levels differed considerably between minimally-recoded and codon-optimized versions of mitochondrial genes.
“Finding that the levels of allotopic gene expression and protein levels differed considerably between minimally-recoded and codon-optimized versions of mitochondrial genes”
Quote in the paperSubstantial claim - Findingown data
Expressing the codon-optimized ATP8 gene from the nucleus can rescue function in a patient cell line null for the ATP8 protein.
“we demonstrate that expressing the codon optimized ATP8 gene from the nucleus can 1) rescue function in a patient cell line null for the ATP8 protein”
Quote in the paperSubstantial claim - Findingown data
For Glutamine, the nuclear genome strongly favors CAG over rarely used CAA, the predominant codon used in recoded genes.
“of the two codons for Glutamine, the nuclear genome demonstrates strong bias for CAG over rarely used CAA, the predominant codon used for Glutamine in recoded genes.”
Quote in the paperNot a substantial claim - Findingown data
Eight of the codon-optimized genes were expressed stably at the protein level.
“In total, eight of the codon-optimized genes were expressed stably at the protein level”
Quote in the paperSubstantial claim - Findingown data
Mutant cells expressing HA-tagged oND1 showed no significant difference in viability in either glucose or galactose media relative to ND1 null controls.
“Mutant cells expressing the HA-tagged oND1 showed no significant difference in viability in either glucose or galactose media relative to ND1 null controls”
Quote in the paperSubstantial claim - Findingown data
In stably selected HEK293 cells, codon-optimized constructs for oND5, oCYB, oCOX1, oCOX3, and oATP6 failed to maintain strong protein expression in mitochondria-enriched fractions.
“codon-optimized constructs for oND5, oCYB, oCOX1, oCOX3, and oATP6 failed to maintain strong protein expression in mitochondria-enriched fractions from stably selected HEK293 cells”
Quote in the paperSubstantial claim - Findingown data
The expressed mouse ATP8 protein integrated into Complex V on BN PAGE gels.
“The expressed protein was also able to integrate into CV on BN PAGE gels (Fig. 6C).”
Quote in the paperSubstantial claim - Findingown data
Steady-state mRNA level of oATP8 was approximately 28-fold higher than rATP8 in stably selected A8/A6mut cells.
“with a notable ~28 fold increase in oATP8 mRNA over rATP8 mRNA.”
Quote in the paperSubstantial claim - Findingown data
Expression levels of the codon-optimized oATP8 gene were many-fold higher than for minimally-recoded rATP6.
“We observed that expression levels of the codon-optimized oATP8 gene were many-fold higher than for minimally-recoded rATP6.”
Quote in the paperSubstantial claim - Findingown data
Integration efficiency of FLAG-tagged oND1 is not sufficient to restore activity to wild-type levels in a homoplasmic ND1 null mtDNA background.
“while some of the FLAG-tagged construct does incorporate into a functional complex, integration efficiency is not sufficient to restore activity to wild-type levels in a homoplasmic ND1 null mtDNA background.”
Quote in the paperSubstantial claim - Findingown data
Neither the processed nor unprocessed form of ND1 was detected when ND1m cells were transfected with the minimally-recoded gene.
“Neither the processed nor unprocessed form of ND1 was detected when cells were transfected with the minimally-recoded gene.”
Quote in the paperSubstantial claim - Findingown data
No minimally-recoded gene produced a reliably detectable protein product following stable selection in mitochondrial fractions aside from rND4.
“no minimally-recoded gene produced a reliably detectable protein product following stable selection in mitochondrial fractions (Fig. 3C) aside from rND4”
Quote in the paperSubstantial claim - Findingown data
Expression of oND1 did not significantly increase the rate of glycolytic growth in the ND1m cell line.
“Expression of oND1 did not significantly increase the rate of glycolyic growth in this cell line”
Quote in the paperSubstantial claim - Findingown data
ATP8 mutant mouse cells suffered a relative growth defect when grown on either glucose or galactose.
“we did find that the ATP8 mutant mouse cells suffered a relative growth defect when grown on either glucose or galactose.”
Quote in the paperSubstantial claim - Findingown data
In stably selected HEK293 cells, codon-optimized versions of 8 mitochondrially-encoded subunits maintained protein production stably, including 6 of 7 Complex I subunits (oND1, oND2, oND3, oND4, oND4L, oND6), Complex IV subunit oCOX2, and oATP8.
“codon-optimized versions of the other 8 mitochondrially-encoded subunits maintained protein production stably, including 6 of the 7 Complex I (CI) subunits (oND1, oND2, oND3, oND4, oND4L, and oND6), Complex IV (CIV) subunit oCOX2, and oATP8 of Complex V (CV)”
Quote in the paperSubstantial claim - Findingown data
Expressing the codon-optimized ATP8 gene from the nucleus can compete with pre-existing mutant proteins in mouse cell lines defective for ATP8 protein function.
“2) compete with pre-existing mutant proteins in mouse cell lines defective for ATP8 protein function.”
Quote in the paperSubstantial claim - Findingcitation
Protein import and complex incorporation of oND1 were notably more robust when expressed in ND1 cybrids with partial reversion of the mutation (ND1m/+) than in homoplasmic ND1m cells.
“we also found protein import and complex incorporation to be notably more robust when expressed in ND1 cybrids with partial reversion of the mutation (ND1m/+), that is, some wild-type ND1 present [34].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Iommarini, 2018, Unravelling the effects of the mutation m.3571insC/MT-ND1 on respiratory complexes structural organization, Int. J. Mol. Sci. source
- Findingown data
Similar codon usage patterns are observed for Lysine, Arginine, Glutamic Acid, and Leucine.
“Similar usage patterns are also observed for the charged amino acids Lysine, Arginine, and Glutamic Acid, and for highly abundant Leucine”
Quote in the paperNot a substantial claim - Findingown data
Both minimally-recoded and codon-optimized versions of each gene express at a level at least equivalent to endogenous COX10 in stably-selected HEK293 cells.
“Both minimally-recoded and codon-optimized versions of each gene express at a level at least equivalent to endogenous COX10”
Quote in the paperSubstantial claim - Findingown data
The FLAG-tagged oND1 protein could be detected in a high molecular weight complex on Native PAGE, which comigrates with endogenous CI subunits GRIM19 and NDUFA9.
“The FLAG-tagged oND1 protein could be detected in a high molecular weight complex on Native PAGE, (Fig. 4D, panel i) which comigrates with endogenous CI subunits GRIM19 (Fig. 4D, panel ii), and NDUFA9 (Fig. 4D, panel iii).”
Quote in the paperSubstantial claim - Findingown data
In transiently transfected HEK293 cells, only 3 of 13 minimally-recoded mitochondrial genes (rND3, rCOX1, rATP8) produced proteins detectable in mitochondrial fractions.
“only 3 of the 13 minimally-recoded mitochondrial genes (rND3, rCOX1, and rATP8) produced proteins detectable in mitochondrial fractions of transiently transfected HEK293 cells”
Quote in the paperSubstantial claim - Findingown data
Following doxycycline induction, allotopically expressed ATP8 protein levels were observably greater with oAtp8 than with rAtp8 in C57/BL6(mtFVB) fibroblasts.
“Following induction with doxycycline, allotopically expressed ATP8 protein levels were observably greater with expression of oAtp8 than with rAtp8 (Fig. 6B), as in the null model system.”
Quote in the paperSubstantial claim - Findingown data
In HEK293 cells, transient expression of both recoded and codon-optimized ATP8 produced detectable protein in mitochondrial fractions.
“Transient ATP8 expression indicated that protein products of both recoded and codon-optimized ATP8 genes were detected in mitochondrial fractions of HEK293 cells (Fig. 2B)”
Quote in the paperSubstantial claim - Findingown data
When cultured in galactose media, viability was modestly yet significantly increased to nearly half wild-type levels when FLAG-tagged oND1 was expressed.
“when cultured in galactose media, viability was modestly, yet significantly increased to nearly half wild-type levels when the FLAG-tagged oND1 was expressed.”
Quote in the paperSubstantial claim - Findingreasoning
When cultured in the presence of glucose, ND1m cells grew at less than 25% the rate of wild type 143B.
“When cultured in the presence of glucose, ND1m cells grew at less than 25% the rate of wild type 143B.”
Quote in the paperSubstantial claim - Findingown data
Mutant cells expressing optimized msoATP8 grew significantly better than non-complemented cells under either growth condition.
“Mutant cells expressing optimized msoATP8, however, grew significantly better than non-complemented cells under either growth condition (Fig. 6D).”
Quote in the paperSubstantial claim - Findingown data
In stably-selected HEK293 cells, transcripts for each codon-optimized gene were substantially higher than its minimally-recoded counterpart, with differences ranging from 5-180 fold.
“in every case, transcripts for the codon-optimized gene was substantially higher than its minimally-recoded counterpart, with differences ranging from 5-180 fold between pairs”
Quote in the paperSubstantial claim - Findingown data
mRNA expression for the codon-optimized ND1 construct was ~210 fold higher than the minimally-recoded version in stably selected ND1m cells.
“mRNA expression for the codon-optimized ND1 constructs was far in excess (~210 fold) of the minimally-recoded version”
Quote in the paperSubstantial claim - Findingown data
Several amino acids in recoded genes are encoded predominantly by synonymous codons that are overwhelmingly underrepresented in the nuclear genome.
“Several amino acids in recoded genes are encoded predominantly by synonymous codons which are overwhelmingly underrepresented in the nuclear genome.”
Quote in the paperSubstantial claim - Findingown data
In the A8/A6mut null cell line, only the codon-optimized ATP8 protein is produced under stable expression.
“Similarly, only the codon-optimized ATP8 protein is produced under stable expression in the A8/A6mut null cell line (Fig. 5C).”
Quote in the paperSubstantial claim - Findingown data
Plotting RSCU values as a heatmap revealed notable differences in codon use patterns.
“When RSCU values were plotted as a heatmap, some notable differences in codon use patterns emerged (Fig. 7A).”
Quote in the paperNot a substantial claim - Findingown data
The ND1 null mutation is prone to reverting to a heteroplasmic state under prolonged culture conditions.
“under prolonged culture conditions we have found that the ND1 null mutation is prone to reverting to a heteroplasmic state.”
Quote in the paperSubstantial claim - Interpretationown data
The rescue capacity of allotopic expression constructs is gene specific.
“the rescue capacity of allotopic expression constructs to be gene specific”
Quote in the paperSubstantial claim - Interpretationreasoning
Codon optimization is an essential consideration in the design of allotopic expression constructs for mitochondrial genes.
“it is an essential consideration in their design”
Quote in the paperSubstantial claim - Interpretationown data
Codon-optimization alone is not sufficient for functional allotopic expression of most mitochondrial genes.
“though codon-optimization alone is not sufficient for functional allotopic expression of most mitochondrial genes”
Quote in the paperSubstantial claim - Premisecitation
Multiple attempts to express mitochondrial genes allotopically have produced inconsistent and at times contradictory results.
“multiple attempts have been made to express mitochondrial genes allotopically, however results have been inconsistent and, at times, contradictory”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [28,[31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [32] Gearing, 1986, Yeast mitochondrial ATPase subunit 8, normally a mitochondrial gene product, expressed in vitro and imported back into the organelle, EMBO J. source
- cites [33] Guy, 2002, Rescue of a mitochondrial deficiency causing leber hereditary optic neuropathy, Ann. Neurol. source
- Premisereasoning
The minimal recoding approach fails to account for other elements of primary sequence that can critically influence gene and protein expression.
“this minimal approach fails to account for other elements of primary sequence which can critically influence both gene and protein expression.”
Quote in the paperSubstantial claim - Interpretationreasoning
Codon optimization of the target gene would not be expected to promote localization or processing of its encoded product, properties typically conferred by the protein sequence.
“Codon optimization of the target gene would not be expected to promote localization or processing of its encoded product, both of which are properties that are typically conferred by the protein sequence.”
Quote in the paperNot a substantial claim - Premisecitation
The C57/BL6(mtFVB) mouse model was created by backcrossing the FVB model onto the C57/BL6 background.
“the model has been backcrossed onto the C57/BL6 background [88,89], resulting in the C57/BL6(mtFVB) mouse model.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [88] Yu, 2009, Dissecting the effects of mtDNA variations on complex traits using mouse conplastic strains, Genome Res. source
- cites [89] Schroder, 2016, Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis, Mol Metab source
- Interpretationnone given
This study is the first to demonstrate the application of codon-optimization for the allotopic expression of all 13 human mitochondrial genes.
“In this study, we are the first to demonstrate the application of codon-optimization, typically employed in heterologous expression systems, for the allotopic expression of all 13 human mitochondrial genes.”
Quote in the paperSubstantial claim - Interpretationown data
Codon optimization facilitates the production of protein in an amount sufficient to observe an effect.
“we find it apparent that codon optimization facilitates the production of protein in an amount sufficient to observe an effect.”
Quote in the paperSubstantial claim - Interpretationown data
The presence of HA-oND1 in a non-functional monomeric CI suggests that properties of the C-terminal tag may influence CI and supercomplex assembly profiles.
“the presence of HA-oND1 in a non-functional monomeric CI suggests that properties of the C-terminal tag may influence CI and supercomplex assembly profiles.”
Quote in the paperSubstantial claim - Interpretationown data
The efficiency of transgene import and complex integration may be influenced by mutation severity and associated secondary characteristics such as altered mitochondrial membrane potential or the absence/presence of preexisting complex structures to act as scaffolds.
“these data suggest that the efficiency of transgene import and complex integration may be influenced by mutation severity and associated secondary characteristics, such as altered mitochondrial membrane potential or the absence/presence of preexisting complex structures to act as scaffolds”
Quote in the paperNot a substantial claim - Interpretationreasoning
The appended MTS of many target genes, both recoded and optimized, may not be appropriately cleaved.
“our results suggest that the appended MTS of many target genes, both recoded and optimized, may not be appropriately cleaved.”
Quote in the paperSubstantial claim- Rests on an assumption: The N-terminal MTS from ATP5G1 directs the target protein to the mitochondrial matrix and is then cleaved by the matrix processing peptidase upon entry through the translocase of the inner membrane.
- Interpretationown data
Codon optimization of transgenes greatly enhances the transient expression of allotopically expressed proteins.
“implying that codon optimization of transgenes greatly enhances the transient expression of allotopically expressed proteins”
Quote in the paperSubstantial claim - Premisereasoning
Cells with the m.3751insC mutation are functionally null for the ND1 protein.
“Cells with this mutation are functionally null for the ND1 protein.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [73] Lim, 2016, Loss of mitochondrial DNA-encoded protein ND1 results in disruption of complex I biogenesis during early stages of assembly, FASEB J. source
- cites [79] McKenzie, 2014, Capture of somatic mtDNA point mutations with severe effects on oxidative phosphorylation in synaptosome cybrid clones from human brain, Hum. Mutat. source
- Interpretationreasoning
The endogenous ATP5G1 MTS sequence is recognized by the processing peptidase of the mitochondrial matrix and would not be cleaved if the N-terminus of an allotopically expressed protein first adopts an orientation facing the intermembrane space.
“the endogenous ATP5G1 MTS sequence is recognized by the processing peptidase of the mitochondrial matrix, and therefore would not be cleaved if the N-terminus of an allotopically expressed protein first adopts an orientation facing the intermembrane space (IMS).”
Quote in the paperSubstantial claim- Rests on an assumption: The endogenous ATP5G1 MTS sequence is recognized by the processing peptidase of the mitochondrial matrix.
- Interpretationown data
oND1 cannot fully complement the m.3751insC mutation in a homoplasmic null model.
“although oND1 cannot fully complement the m.3751insC mutation in a homoplasmic null model”
Quote in the paperSubstantial claim - Interpretationown data
Optimizing mitochondrial coding sequences to adapt to nuclear codon patterns is a critical step for successful expression of these genes from the nucleus.
“Our results indicate that optimizing mitochondrial coding sequences to adapt to nuclear codon patterns is a critical step for the successful expression of these genes from the nucleus.”
Quote in the paperSubstantial claim
- It may state two separate claims as one. 34
- Probably not a substantial claim. 22
- The quote only partly states this claim. 1
It may state two separate claims as one.
Findingown dataEight of thirteen mitochondria-encoded oxidative phosphorylation (OxPhos) proteins maintained protein expression following stable selection, with mitochondrial localization of expression products.
“Eight of thirteen mitochondria-encoded oxidative phosphorylation (OxPhos) proteins maintained protein expression following stable selection, with mitochondrial localization of expression products.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataOf all thirteen minimally recoded genes, only rND4 demonstrated any stable protein expression, and this was only a fraction of that detected for oND4 under similar conditions.
“Of all thirteen minimally recoded genes, only rND4 demonstrated any protein expression stably; however, this was only a fraction of that detected for oND4 under similar conditions.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingnone givenWe have developed a protocol to enrich mitochondria from limited numbers of mammalian cells.
“We have developed a protocol to rapidly and economically enrich mitochondria from limited numbers of mammalian cells.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataSevere mutations in mitochondrial subunits, such as the ND1m mutant line, disrupt OXPHOS to a degree that proliferation rates are markedly reduced even under normal growth conditions, with dramatically impaired viability in glucose-restricted media demanding oxidative metabolism.
“Severe mutations in mitochondrial subunits, such that of the ND1m mutant line, disrupt OXPHOS to a degree that proliferation rates are markedly reduced even under normal growth conditions, with dramatically impaired viability in glucose-restricted media demanding oxidative metabolism.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataWhen cultured in glucose-containing media, ND1m cells proliferated at approximately 25% the rate of wild-type 143B cells, and growth rate of ND1m cells expressing a tagged oND1 was not significantly increased from the mutant.
“when cultured in glucose-containing media, ND1m cells appeared to proliferate at approximately 25% the rate of wild-type 143B cells, and growth rate of ND1m cells expressing a tagged oND1 was not significantly increased from the mutant.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn partially reverted ND1m/+ lines, the FLAG epitope incorporates into both Complex I monomers and supramolecular structures, comigrating with endogenous ND1 subunit.
“In partially reverted ND1m/+ lines, the FLAG epitope clearly incorporates into both Complex I monomers and supramolecular structures, comigrating with the endogenous ND1 subunit”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataCodon-optimized oND1 can incorporate and partially restore OxPhos function in an ND1 null background, with greatly enhanced incorporation under heteroplasmic ND1m/+ conditions.
“We also show that codon optimized oND1 can incorporate and partially restore OxPhos function in an ND1 null background, with greatly enhanced incorporation under heteroplasmic ND1m/+ conditions.”
Quote in the paperSubstantial claimProbably not a substantial claim.
Findingnone givenThe ND1m cell line demonstrates markedly slower growth under glucose conditions relative to wild-type.
“Because the ND1m line demonstrates markedly slower growth under glucose conditions relative to wild-type”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataThe majority of mRNAs from stably-selected HEK293 cells are equal or one to two orders of magnitude lower in expression than GAPDH mRNA, and the most robustly expressed optimized gene (oND3) is present at no more than 1.38 times GAPDH.
“the majority of mRNAs are equal or one to two orders of magnitude lower in expression than the mRNA of housekeeping gene GAPDH (Fig. 3B), and the most robustly expressed optimized genes are present at no more than 1.38 times GAPDH (for oND3)”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataComplex I-associated Complex III was only present in WT mitochondria and those expressing oND1, confirming failed CI/III association in the ND1 null line and supporting some restored complex assembly upon allotopic expression of codon-optimized ND1 subunit.
“Complex I-associated Complex III was only present in WT mitochondria and those expressing oND1, as evidenced by the comigration of CIII with the GRIM-19 and NDUFA9 subunits of CI, thus confirming failed CI/III association in the ND1 null line and supporting some restored complex assembly upon allotopic expression of the codon-optimized ND1 subunit”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataUnder DDM conditions, monomeric CI is observed exclusively in wild-type 143B mitochondria and in ND1m mitochondria with allotopically-expressed oND1-FLAG, and is entirely absent in the ND1 null line.
“Under these conditions, monomeric CI is observed exclusively in wild-type 143B mitochondria and in ND1m mitochondria with allotopically-expressed oND1-FLAG, and is entirely absent in the ND1 null line.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataOf the minimally-recoded versions, only rND4 had any appreciable protein expression in stably selected HEK293 cells, though at levels well below its codon-optimized counterpart.
“of the minimally-recoded versions for each gene, only rND4 had any appreciable protein expression, though with detectable levels still well below its codon-optimized counterpart”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataAll recoded genes demonstrate strongly biased use of underrepresented codons UUA or CUA, and none use the dominant CUG codon.
“none use the dominant CUG codon, and all recoded genes instead demonstrate strongly biased use of underrepresented codons UUA or CUA.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataViability of wild type 143B cells was reduced to ~55% when cultured in OxPhos restrictive media, and ND1m cells were only ~11% viable.
“the viability of wild type 143B cells was reduced to ~55% its viability when cultured in OxPhos restrictive media, and ND1m cells were only ~11% viable.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataStably selected ND1m cells coding for oND1 expressed the FLAG epitope on denaturing western blots of mitochondrial protein isolates, with a major product at ~37 kDa and a minor product near 60 kDa, corresponding to processed and unprocessed ND1 products.
“Stably selected ND1m cells coding for oND1 expressed the FLAG epitope on denaturing western blots of mitochondrial protein isolates (Fig. 4C), with a major product detected at ~ 37 kDa and a minor product near 60 kDa, corresponding to the processed and unprocessed ND1 products, respectively.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingnone givenLeucine constitutes 17% of the residues in mitochondrial protein-coding genes.
“which alone constitutes 17% of the residues in mitochondrial protein-coding genes.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataCI-linked activity in-gel was present in CI monomers in wild-type and oND1-expressing mitochondria, with no detectable CI function in the ND1 mutant cell line, suggesting that incorporated FLAG-tagged ND1 protein can support functional Complex I activity.
“Activity in wild-type and oND1-expressing mitochondria was present in CI monomers when lysed with DDM, with no detectable CI function in the ND1 mutant cell line (Fig. 4E), suggesting that the incorporated FLAG-tagged ND1 protein can indeed support functional Complex I activity.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenA no-template control was included in each reaction set to rule out non-specific priming.
“A no-template control was included in each reaction set to rule out non-specific priming.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductown dataHomoplasmy in the mouse cell lines was ascertained by Sanger sequencing.
“Homoplasmy in the mouse cell lines C57/BL6(WT), C57/BL6(mtFVB) and C57/BL6(mtFVB) stably expressing doxycycline inducible allotopic MsoATP8 was ascertained by Sanger sequencing using the primer indicated in Fig. S3B.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationThe C57/BL6(mtFVB) mutation has been shown to cause various defects in inbred mice including anxiety and inflammation-related arthritis.
“The C57/BL6(mtFVB) mutation has been shown to cause various defects in inbred mice including anxiety and inflammation-related arthritis [91,92].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [91] Weiss, 2012, The mitochondrial Atp8 mutation induces mitochondrial ROS generation, secretory dysfunction, and beta-cell mass adaptation in conplastic B6-mtFVB mice, Endocrinology source
- cites [92] Yu, 2009, The mtDNA nt7778 G/T polymorphism affects autoimmune diseases and reproductive performance in the mouse, Hum. Mol. Genet. source
It may state two separate claims as one.
Interpretationown dataOptimizing the primary sequence of mitochondrial genes facilitates their nuclear expression in human cells and, in some cases, their assembly into respiratory complexes.
“Here, we have demonstrated that merely optimizing the primary sequence of mitochondrial genes facilitates their nuclear expression in human cells, and in some cases, their assembly into respiratory complexes”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationMitochondrial-nuclear crosstalk is well documented, and evidence suggests that mutations in the mitochondrial genome influence nuclear gene expression profiles even when phenotypes are mild.
“mitochondrial-nuclear crosstalk is well documented, and evidence suggests that mutations in the mitochondrial genome also influence nuclear gene expression profiles, even when phenotypes are mild [94].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] Latorre-Pellicer, 2016, Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing, ON Nat. source
It may state two separate claims as one.
PremisecitationThe mutation m.3751insC in MT-ND1 introduces an additional C into a homopolymeric cytosine stretch, resulting in a premature stop codon (p.Leu89Profs*13) and truncation of the 318 amino acid protein product to 100 residues.
“This mutation introduces an additional C into a homopolymeric cytosine stretch in the first third of MT-ND1 (m.3751insC), resulting in a premature stop codon (p.Leu89Profs*13) and truncation of the 318 amino acid protein product to 100 residues”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [73] Lim, 2016, Loss of mitochondrial DNA-encoded protein ND1 results in disruption of complex I biogenesis during early stages of assembly, FASEB J. source
- cites [79] McKenzie, 2014, Capture of somatic mtDNA point mutations with severe effects on oxidative phosphorylation in synaptosome cybrid clones from human brain, Hum. Mutat. source
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Interpretationnone givenThe method is comparable to commercially available kits.
“and is comparable to commercially available kits”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductcitationARMS qPCR was used to ascertain mutation load in cybrids during the study.
“We used Amplification Refractory Mutation System-quantitative PCR (ARMS qPCR) [95] to ascertain mutation load in cybrids during the course of this study.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Bai, 2004, Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach, Clin. Chem. source
Probably not a substantial claim. The paper may give no reason why it holds.
Premisenone givenA critical but often-overlooked consideration in nuclear relocation studies is the influence of the primary coding sequence on protein production.
“A critical, but often-overlooked consideration in these nuclear relocation studies, however, is the influence of the primary coding sequence on protein production.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationND1 has previously been allotopically expressed to demonstrate the necessity of functional CI in the hypoxia-induced shift to a Warburg profile during tumorigenesis, but this was also only achieved under conditions of heteroplasmy.
“ND1 has previously been allotopically expressed to demonstrate the necessity of functional CI in the hypoxia-induced shift to a Warburg profile during tumorigenesis, however this was also only achieved under conditions of heteroplasmy [30].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Nagley, 1989, Leading organellar proteins along new pathways: the relocation of mitochondrial and chloroplast genes to the nucleus, Trends Biochem. Sci. source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationThe protease cleavage site of the ATP5G1 MTS has been determined, and the first five amino acids of mature ATP5G1 protein were included to facilitate processing.
“The protease cleavage site of this MTS has been determined and, for this study, we also included the first five amino acids of the mature ATP5G1 protein to facilitate processing of the precursor [36].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Manfredi, 2002, Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus, Nat. Genet. source
The quote only partly states this claim.
Study design and conductown dataHomoplasmy was preserved throughout the duration of lengthy experiments, as tested by ARMS qPCR at various time points.
“in order to confirm that homoplasmy was preserved throughout the duration of lengthy experiments, we tested the mutation load in cybrid cell lines at various time points by ARMS qPCR.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataCodon-optimized genes are comprised overwhelmingly of codons with nuclear use bias and avoid rare codons, likely contributing to their enhanced nuclear expression over minimally recoded versions.
“codon-optimized genes are comprised overwhelmingly of codons which show use bias in nuclear genes and avoid the use of underrepresented, or rare codons, likely contributing to their enhanced nuclear expression over minimally recoded versions.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Interpretationnone givenThe method is suitable to process multiple samples in parallel.
“This method is suitable to process multiple samples in parallel”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationIn the absence of wild-type ND1, Complex I fails to assemble, resulting in impaired oxidative metabolism and failure to grow in galactose media.
“In the absence of wild-type ND1, Complex I fails to assemble, resulting in impaired oxidative metabolism and failure to grow in galactose media [34,80].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34] Iommarini, 2018, Unravelling the effects of the mutation m.3571insC/MT-ND1 on respiratory complexes structural organization, Int. J. Mol. Sci. source
- cites [80] Antonicka, 2003, Identification and characterization of a common set of complex I assembly intermediates in mitochondria from patients with complex I deficiency, J. Biol. Chem. source
It may state two separate claims as one.
PremisecitationThe authors previously reported successful allotopic expression of MT-ATP8 and, to a lesser extent, MT-ATP6, with functional rescue in the A8/A6mut cybrid null for ATP8 protein.
“We previously reported the successful allotopic expression of the MT-ATP8 gene and to a lesser extent the MT-ATP6 gene, with functional rescue in a cybrid cell line A8/A6mut (m.8529G-A) null (Fig. 5A) for the ATP8 protein [87].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Boominathan, 2016, Stable nuclear expression of ATP8 and ATP6 genes rescues a mtDNA Complex V null mutant, Nucleic Acids Res. source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationMT-ATP8 and MT-ATP6 are mtDNA-encoded subunits of ATP synthase, while the remaining subunits are nuclear-encoded.
“Two of the subunits of this multimeric complex are encoded by mtDNA, namely MT-ATP8 and MT-ATP6, whereas, the genes for the remaining subunits reside in the nucleus [84].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] Jonckheere, 2012, Mitochondrial ATP synthase: architecture, function and pathology, J. Inherit. Metab. Dis. source
It may state two separate claims as one.
PremisecitationC57/BL6(mtFVB) mice demonstrate measurable phenotypes and their cells in vitro have subtle deficits indicative of disrupted Complex V function.
“C57/BL6(mtFVB) mice demonstrate measurable phenotypes and cells in vitro have subtle deficits indicative of disrupted CV function [90,91]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [90] Eipel, 2011, Mutation of mitochondrial ATP8 gene improves hepatic energy status in a murine model of acute endotoxemic liver failure, Life Sci. source
- cites [91] Weiss, 2012, The mitochondrial Atp8 mutation induces mitochondrial ROS generation, secretory dysfunction, and beta-cell mass adaptation in conplastic B6-mtFVB mice, Endocrinology source
Probably not a substantial claim.
Study design and conductcitationThe A8/A6mut cells were selected for homoplasmy as described previously.
“The A8/A6mut cells were selected for homoplasmy as described previously [87].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Boominathan, 2016, Stable nuclear expression of ATP8 and ATP6 genes rescues a mtDNA Complex V null mutant, Nucleic Acids Res. source
It may state two separate claims as one.
InterpretationreasoningA heteroplasmic model remains more representative of dysfunctional mitochondrial conditions in affected patients, and therefore incorporation of allotopically expressed subunits in this context remains a clinically relevant result.
“a heteroplasmic model remains more representative of dysfunctional mitochondrial conditions in affected patients, and therefore the incorporation of allotopically expressed subunits in this context remains a clinically relevant result.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisereasoningMinimally-recoded gene sequences largely reflect mitochondrial codon preferences, while codon-optimized genes should have coding patterns more similar to nuclear genes.
“Because minimally-recoded gene sequences have only the changes necessary to preserve the amino acid sequence of a protein, they largely reflect codon preferences of the mitochondrial genome, while genes codon-optimized for nuclear expression should demonstrate coding patterns more similar to those of nuclear genes.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
InterpretationreasoningThe high bias toward underrepresented nuclear codons for these amino acids reflects a preference for these codons in mitochondrial translation and suggests they may be poorly translated in the cytosolic context.
“the high bias toward underrepresented nuclear codons for these amino acids reflects a preference for these codons in mitochondrial translation, and meanwhile suggests they may be poorly translated in the cytosolic context.”
Quote in the paperSubstantial claim- Rests on an assumption: Synonymous codon use of a genome can be loosely associated with translation.
Probably not a substantial claim.
Premisenone givenThe vast majority of previous allotopic expression studies have utilized minimally-recoded mitochondrial genes, wherein only bases differing from the universal genetic code are changed.
“The vast majority of these previous studies have utilized what may be considered “minimally-recoded” mitochondrial genes, wherein the only bases changed are those which differ from the universal genetic code (Trp, Met, Stop)”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataMitochondrial genes utilize synonymous codons differently than nuclear genes, featuring a high percentage of codons rare or underrepresented in the nuclear genome, which may account for poor or absent allotopic expression of minimally-recoded genes.
“Analysis of codon use patterns in minimally-recoded and codon-optimized gene constructs revealed that mitochondrial genes indeed utilize synonymous codons differently than nuclear genes, featuring a high percentage of codons considered to be rare or underrepresented in the nuclear genome, which may account for the poor or absent allotopic expression of minimally-recoded genes.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationElements including relative frequencies of codon use, local and global GC composition, mRNA secondary structure stability, and presence of cryptic termination signals or splice sites are significant factors impacting protein expression.
“elements including the relative frequencies of codon use for each amino acid, local and global GC composition, mRNA secondary structure stability, and the presence of cryptic termination signals or splice sites are significant factors impacting the degree of protein expression”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [61] Hanson, 2018, Codon optimality, bias and usage in translation and mRNA decay, Nat. Rev. Mol. Cell Biol. source
- cites [62] Inouye, 2015, Codon optimization of genes for efficient protein expression in mammalian cells by selection of only preferred human codons, Protein Expr. Purif. source
- cites [63] Stachyra, 2016, Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens, Virol. J. source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Interpretationnone givenThe protocol rapidly and economically enriches mitochondria from limited numbers of mammalian cells.
“to rapidly and economically enrich mitochondria from limited numbers of mammalian cells”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
InterpretationreasoningThe codon use profiles of mitochondrial genes are significant in facilitating heterologous nuclear expression and promoting effective translation.
“the codon use profiles of mitochondrial genes are significant in facilitating heterologous nuclear expression and promoting effective translation.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationPathological mutations in MT-ATP8 and MT-ATP6 manifest as NARP, MILS, and cardiac hypertrophy.
“Several pathological mutations in these two mtDNA subunits have been reported and manifest as NARP (Neuropathy, Ataxia, and Retinitis Pigmentosa), MILS (Maternally Inherited Leigh Syndrome) (www.mitomap.org), and cardiac hypertrophy [85,86] in patients.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [85] Jonckheere, 2008, A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy, J. Med. Genet. source
- cites [86] Ware, 2009, Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes, J. Med. Genet. source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationThe F1Fo ATP synthase is the terminal complex in oxidative phosphorylation and converts the proton motive force generated by Complexes I, III and IV into ATP.
“The F1Fo ATP synthase is the terminal complex in the oxidative phosphorylation relay and is responsible for converting the proton motive force generated by Complexes I, III and IV into ATP.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] Jonckheere, 2012, Mitochondrial ATP synthase: architecture, function and pathology, J. Inherit. Metab. Dis. source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationBoth inherited and acquired mutations in mtDNA cause severe diseases including LHON, Leigh's syndrome, MELAS, MERRF, NARP and MILS, Kern-Sayer's syndrome, and reversible respiratory chain syndrome.
“Both inherited and acquired mutations in mtDNA cause severe diseases, including LHON, Leigh’s syndrome, MELAS, MERRF, NARP and MILs, Kern-Sayer’s syndrome, and reversible respiratory chain syndrome (reviewed in 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Chinnery, 2000, Mitochondrial DNA mutations in the pathogenesis of human disease, Mol. Med. Today source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationmtDNA mutations accumulate with age and accompany a progressive decline in organelle function.
“mtDNA mutations also accumulate with age and accompany a progressive decline in organelle function [4].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Schaefer, 2008, Prevalence of mitochondrial DNA disease in adults, Ann. Neurol. source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductreasoningRSCU values were calculated to address inherent bias due to the codon composition of hydrophobic amino acids.
“therefore RSCU values were calculated to address inherent bias due to the codon composition of hydrophobic amino acids (Table S2).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Interpretationown dataAlthough changes to coding sequence alone may not be sufficient for complete complementation of all mtDNA genes, host nuclear codon optimization is, for most, sufficient for stable expression.
“we conclude that although making changes to coding sequence alone may not be sufficient for complete complementation of all mtDNA genes, host (nuclear) codon optimization is, for most, sufficient for stable expression”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationClinical gene therapy using a codon-optimized exogenous construct to compensate for mutations in a nuclear gene is ongoing.
“clinical gene therapy using a codon-optimized exogenous construct to compensate for mutations in a nuclear gene (e.g. hemophilia, [69]) is ongoing”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Rangarajan, 2017, AAV5-Factor VIII gene transfer in severe hemophilia A, N. Engl. J. Med. source
It may state two separate claims as one.
Study design and conductown dataThe ND1m cells were previously shown to be homoplasmic and were confirmed to be >99.9% homoplasmic by ARMS qPCR and Sanger sequencing.
“The ND1m cells were previously shown to be homoplasmic [79] and within our experimental limitations we were able to confirm that these cells were >99.9% homoplasmic by ARMS qPCR (Supplementary Table S4) and Sanger sequencing (Supplementary Fig. S3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] McKenzie, 2014, Capture of somatic mtDNA point mutations with severe effects on oxidative phosphorylation in synaptosome cybrid clones from human brain, Hum. Mutat. source
The paper relies on this without support.
The FVB mouse has a severe Complex V defect caused by several mutations, including the mitochondrial transversion m.7778G-T resulting in an Asp-Tyr substitution within the conserved N-terminus of the ATP8 protein.
“The FVB mouse has a severe CV defect caused by several mutations, including a mitochondrial transversion mutation (m.7778G-T) resulting in an Asp-Tyr substitution within the conserved N-terminus of the ATP8 protein.”
The paper relies on this without support.
The C57/BL6(mtFVB) mouse line is not a null model; the mutant ATP8 protein is synthesized and incorporated into Complex V.
“This is not a null model - the mutant ATP8 protein is synthesized and incorporated into Complex V (CV)”
The paper relies on this without support.
The N-terminal MTS from ATP5G1 directs the target protein to the mitochondrial matrix and is then cleaved by the matrix processing peptidase upon entry through the translocase of the inner membrane.
“Under stable expression conditions, the N-terminal MTS from ATP5G1 directs the target protein to the mitochondrial matrix and is then cleaved by the matrix processing peptidase (MPP) upon entry through the translocase of the inner membrane (TIM).”
The paper relies on this without support.
Charged amino acids directly influence the import and topology of imported mitochondrial proteins.
“Charged amino acids, though not abundant in mitochondrial proteins, are known to directly influence the import and topology of imported mitochondrial proteins.”
The paper relies on this without support.
Synonymous codon use of a genome can be loosely associated with translation.
“As synonymous codon use of a genome can be loosely associated with translation”
The paper relies on this without support.
The endogenous ATP5G1 MTS sequence is recognized by the processing peptidase of the mitochondrial matrix.
“the endogenous ATP5G1 MTS sequence is recognized by the processing peptidase of the mitochondrial matrix”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mitochondrial genes require codon optimization for robust expression from the nucleus.
“Our previous work has addressed several of these challenges as we have shown that mitochondrial genes require codon optimization for robust expression from the nucleus33”
From Exogenous expression of ATP8, a mitochondrial encoded protein, from the nucleus in vivo (2024) · cites this paper as [33]
Only 8 of the 13 codon-optimized genes showed stable expression.
“Only 8 of the 13 codon-optimized genes showed stable expression.”
From Exogenous expression of ATP8, a mitochondrial encoded protein, from the nucleus in vivo (2024) · cites this paper as [33]
The appended MTS (ATP5G1) was not always efficiently processed.
“however, the appended MTS, in this case that of ATP5G1, was not always efficiently processed.33”
From Exogenous expression of ATP8, a mitochondrial encoded protein, from the nucleus in vivo (2024) · cites this paper as [33]
Nuclear codon optimization for all mtDNA genes significantly improves translation and association with mitochondria.
“Our previous studies indicate that nuclear codon optimization for all the mtDNA genes significantly improves translation and association with mitochondria”
From Exogenous expression of ATP8, a mitochondrial encoded protein, from the nucleus in vivo (2024) · cites this paper as [33]
Previously, only a fraction of allotopically expressed mitochondrial protein integrates into the proper mitochondrial complex.
“Previously, we have shown how only a fraction of allotopically expressed mitochondrial protein integrates into the proper mitochondrial complex.27,33”
From Exogenous expression of ATP8, a mitochondrial encoded protein, from the nucleus in vivo (2024) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
ND1 mutation is identified at two different positions
MinorThe same ND1 mutation is identified as m.3571insC and m.3751insC. These specify different positions, so the disease-model mutation is not consistently identified.
“The mutation m.3571insC was originally isolated from a patient glioma”
“This mutation introduces an additional C into a homopolymeric cytosine stretch in the first third of MT-ND1 (m.3751insC)”
ND1 rescue is described as nearly half of wild-type viability
MinorThe Results state that FLAG-tagged oND1 reached 32% of wild-type viability in galactose, whereas the Discussion describes it as nearly half. This materially overstates the reported rescue.
“viability was modestly, yet significantly increased to nearly half wild-type levels when the FLAG-tagged oND1 was expressed”
“with an 18% average total viability, corresponding to 32% of wild-type viability in galactose (Fig. S2C)”
Transient comparison claims all 13 minimally recoded genes were tested
MinorThe abstract claims higher transient expression than minimally recoded genes for all 13 constructs, but the minimally recoded ND6 construct was never synthesized or tested.
“All 13 codon-optimized constructs exhibited substantially higher protein expression than minimally-recoded genes when expressed transiently”
“For Complex I subunit ND6, only expression of the codon-optimized version (oND6) was tested, as the minimally-recoded version repeatedly failed synthesis for unknown reasons.”
Discussion cites the wrong figure for mouse ATP8 viability
MinorThe Discussion cites Fig. 5D for the mouse ATP8 growth result, but the mouse viability assay is identified as Fig. 6D; Fig. 5 concerns the human ATP8 null cell line.
“Mutant cells expressing optimized msATP8, however, grew significantly better than non-complemented cells under either growth condition (Fig. 5D).”
“(D) Viability on galactose media. Wild type (C57/BL6WT), mutant (C57/BL6(mtFVB)) and mutant mouse cells stably expressing oATP8 (C57/BL6(mtFVB) + oATP8) grown in either glucose or galactose media were assessed for viability after 72 h.”
Citations
Cites
Codon optimality, bias and usage in translation and mRNA decay
Hanson, G., & Coller, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.91 · Cited by 825
Human mitochondrial DNA: roles of inherited and somatic mutations
Schon, E. A., DiMauro, S., & Hirano, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3275 · Cited by 757
AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
Rangarajan, S., Walsh, L., Lester, W., Perry, D., Madan, B., Laffan, M., Yu, H., Vettermann, C., Pierce, G. F., Wong, W. Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708483 · Cited by 694
Pathogenic Mitochondrial DNA Mutations Are Common in the General Population
Elliott, H. R., Samuels, D. C., Eden, J. A., Relton, C. L., & Chinnery, P. F. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.07.004 · Cited by 629
Mitochondrial ATP synthase: architecture, function and pathology
Jonckheere, A. I., Smeitink, J. A. M., & Rodenburg, R. J. T. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9382-9 · Cited by 605
Wittig, I., Karas, M., & Schägger, H. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700076-mcp200 · Cited by 552
Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2
Guo, R., Zong, S., Wu, M., Gu, J., & Yang, M. (2017) · Cell · doi:10.1016/j.cell.2017.07.050 · Cited by 515
Shoffner, J. M., Lott, M. T., Voljavec, A. S., Soueidan, S. A., Costigan, D. A., & Wallace, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7952 · Cited by 505
Prevalence of mitochondrial DNA disease in adults
Schaefer, A. M., McFarland, R., Blakely, E. L., He, L., Whittaker, R. G., Taylor, R. W., Chinnery, P. F., & Turnbull, D. M. (2008) · Annals of Neurology · doi:10.1002/ana.21217 · Cited by 494
Respiratory Complex III Is Required to Maintain Complex I in Mammalian Mitochondria
Acín‐Pérez, R., Bayona‐Bafaluy, M. P., Fernández‐Silva, P., Moreno‐Loshuertos, R., Martos, A. P., Bruno, C., Moraes, C. T., & Enrı́quez, J. A. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00124-8 · Cited by 475
Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs
Bacman, S. R., Williams, S. L., Pinto, M., Peralta, S., & Moraes, C. T. (2013) · Nature Medicine · doi:10.1038/nm.3261 · Cited by 432
Understanding mitochondrial complex I assembly in health and disease
Mimaki, M., Wang, X., McKenzie, M., Thorburn, D. R., & Ryan, M. T. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.08.010 · Cited by 420
Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing
Latorre-Pellicer, A., Moreno-Loshuertos, R., Lechuga-Vieco, A. V., Sánchez-Cabo, F., Torroja, C., Acín-Pérez, R., Calvo, E., Aix, E., González-Guerra, A., Logan, A., et al. (2016) · Nature · doi:10.1038/nature18618 · Cited by 377
Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells
Suen, D., Narendra, D. P., Tanaka, A., Manfredi, G., & Youle, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914569107 · Cited by 345
A critical analysis of codon optimization in human therapeutics
Mauro, V. P., & Chappell, S. A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.003 · Cited by 343
Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations
Kang, E., Wu, J., Gutiérrez, N. M., Koski, A., Tippner-Hedges, R., Agaronyan, K., Platero-Luengo, A., Martínez‐Redondo, P., Ma, H., Lee, Y., et al. (2016) · Nature · doi:10.1038/nature20592 · Cited by 327
Significance of Respirasomes for the Assembly/Stability of Human Respiratory Chain Complex I
Schägger, H., de Coo, I. F. M., Bauer, M. F., Hofmann, S., Godinot, C., & Brandt, U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404033200 · Cited by 316
Complex I deficiency: clinical features, biochemistry and molecular genetics
Fassone, E., & Rahman, S. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101159 · Cited by 316
Mitochondrial complex I: structure, function and pathology
Janssen, R. J. R. J., Nijtmans, L. G., Heuvel, L. P. V. D., & Smeitink, J. A. M. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0362-4 · Cited by 276
Bacman, S. R., Kauppila, J. H. K., Pereira, C. V., Nissanka, N., Miranda, M., Pinto, M., Williams, S. L., Larsson, N., Stewart, J. B., & Moraes, C. T. (2018) · Nature Medicine · doi:10.1038/s41591-018-0166-8 · Cited by 271
Respiratory chain complex I deficiency
Kirby, D. M., Crawford, M., Cleary, M., Dahl, H. ‐. M., Dennett, X., & Thorburn, D. R. (1999) · Neurology · doi:10.1212/wnl.52.6.1255 · Cited by 269
Mitochondrial Complex I Plays an Essential Role in Human Respirasome Assembly
Moreno-Lastres, D., Fontanesi, F., García‐Consuegra, I., Martín, M. A., Arenas, J., Barrientos, A., & Ugalde, C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.015 · Cited by 258
Genome signature comparisons among prokaryote, plasmid, and mitochondrial DNA
Campbell, A., Mrázek, J., & Karlin, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9184 · Cited by 249
Manfredi, G., Fu, J., Ojaimi, J., Sadlock, J. E., Kwong, J. Q., Guy, J., & Schon, E. A. (2002) · Nature Genetics · doi:10.1038/ng851 · Cited by 235
Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy
Guy, J., Qi, X., Pallotti, F., Schon, E. A., Manfredi, G., Carelli, V., Martinuzzi, A., Hauswirth, W. W., & Lewin, A. S. (2002) · Annals of Neurology · doi:10.1002/ana.10354 · Cited by 215
Gene Therapy for Leber Hereditary Optic Neuropathy
Guy, J., Feuer, W. J., Davis, J. L., Porciatti, V., Gonzalez, P. J., Koilkonda, R. D., Yuan, H., Hauswirth, W. W., & Lam, B. L. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.016 · Cited by 204
Hashimoto, M., Bacman, S. R., Peralta, S., Falk, M. J., Chomyn, A., Chan, D. C., Williams, S. L., & Moraes, C. T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.126 · Cited by 199
Codon optimization of human factor VIII cDNAs leads to high-level expression
Ward, N. J., Buckley, S. M. K., Waddington, S. N., VandenDriessche, T., Chuah, M., Nathwani, A. C., McIntosh, J., Tuddenham, E. G. D., Kinnon, C., Thrasher, A. J., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282707 · Cited by 186
Johnston, I. G., & Williams, B. P. (2016) · Cell Systems · doi:10.1016/j.cels.2016.01.013 · Cited by 185
A mitochondrial DNA clone is associated with increased risk for Alzheimer disease.
Hutchin, T. P., & Cortopassi, G. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6892 · Cited by 183
Limitations to in vivo Import of Hydrophobic Proteins into Yeast Mitochondria
Claros, M. G., Perea, J., Shu, Y., Samatey, F. A., Popot, J., & Jacq, C. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20321.x · Cited by 169
Antonicka, H., Ogilvie, I., Taivassalo, T., Anitori, R. P., Haller, R. G., Vissing, J., Kennaway, N. G., & Shoubridge, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304998200 · Cited by 161
Diagnosis and Treatment of Mitochondrial Myopathies
Ahmed, S. T., Craven, L., Russell, O. M., Turnbull, D. M., & Vincent, A. E. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-00674-4 · Cited by 160
Perales‐Clemente, E., Fernández‐Silva, P., Acín‐Pérez, R., Martos, A. P., & Enrı́quez, J. A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq769 · Cited by 154
Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
Yang, Y., Wu, H., Kang, X., Liang, Y., Lan, T., Li, T., Tan, T., Peng, J., Zhang, Q., An, G., et al. (2018) · Protein & Cell · doi:10.1007/s13238-017-0499-y · Cited by 136
Bai, R.-K., & Wong, L.-J. C. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.031153 · Cited by 135
Bonnet, C., Augustin, S., Ellouze, S., Bénit, P., Bouaita, A., Rustin, P., Sahel, J.-A., & Corral-Debrinski, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.04.018 · Cited by 130
Sylvestre, J., Margeot, A., Jacq, C., Dujardin, G., & Corral-Debrinski, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0074 · Cited by 129
Mauro, V. P. (2018) · BioDrugs · doi:10.1007/s40259-018-0261-x · Cited by 128
Zhao, F., Yu, C.-H., & Liu, Y. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx501 · Cited by 120
Dissecting the effects of mtDNA variations on complex traits using mouse conplastic strains
Yu, X., Gimsa, U., Wester-Rosenlöf, L., Kanitz, E., Otten, W., Kunz, M., & Ibrahim, S. M. (2009) · Genome Research · doi:10.1101/gr.078865.108 · Cited by 120
Golubitzky, A., Dan, P., Weissman, S., Link, G., Wikström, J. D., & Saada, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026883 · Cited by 112
Limitations of Allotopic Expression of Mitochondrial Genes in Mammalian Cells
Oca‐Cossio, J., Kenyon, L., Hao, H., & Moraes, C. T. (2003) · Genetics · doi:10.1093/genetics/165.2.707 · Cited by 110
Iommarini, L., Kurelac, I., Capristo, M., Calvaruso, M. A., Giorgio, V., Bergamini, C., Ghelli, A. M., Nanni, P., Giovanni, C. D., Carelli, V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt533 · Cited by 107
Nagley, P., Farrell, L. B., Gearing, D. P., Nero, D., Meltzer, S., & Devenish, R. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2091 · Cited by 106
Biochemical and molecular diagnosis of mitochondrial respiratory chain disorders
Thorburn, D. R., Sugiana, C., Salemi, R., Kirby, D. M., Worgan, L. C., Ohtake, A., & Ryan, M. T. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.08.006 · Cited by 105
Jonckheere, A. I., Hogeveen, M., Nijtmans, L. G. J., van den Brand, M. A. M., Janssen, A. J. M., Diepstra, J. H. S., van den Brandt, F. C. A., van den Heuvel, L. P., Hol, F. A., Hofste, T. G. J., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.052084 · Cited by 104
Bonnet, C., Kaltimbacher, V., Ellouze, S., Augustin, S., Bénit, P., Forster, V., Rustin, P., Sahel, J.-A., & Corral-Debrinski, M. (2007) · Rejuvenation Research · doi:10.1089/rej.2006.0526 · Cited by 98
Kaltimbacher, V., Bonnet, C., Lecoeuvre, G., Forster, V., Sahel, J., & Corral‐Debrinski, M. (2006) · RNA · doi:10.1261/rna.18206 · Cited by 95
Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells
Calabrese, C., Iommarini, L., Kurelac, I., Calvaruso, M. A., Capristo, M., Lollini, P., Nanni, P., Bergamini, C., Nicoletti, G., Giovanni, C. D., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-11 · Cited by 94
Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation
Dai, Y., Zheng, K., Clark, J., Swerdlow, R. H., Pulst, S. M., Sutton, J. P., Shinobu, L. A., & Simon, D. K. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt450 · Cited by 92
Marella, M., Seo, B. B., Thomas, B. B., Matsuno‐Yagi, A., & Yagi, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011472 · Cited by 90
Cwerman-Thibault, H., Augustin, S., Lechauve, C., Ayache, J., Ellouze, S., Sahel, J.-A., & Corral-Debrinski, M. (2015) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2015.3 · Cited by 86
Ware, S. M., El-Hassan, N., Kahler, S. G., Zhang, Q., Y-W, Miller, E., Wong, B., Spicer, R. L., Craigen, W. J., Kozel, B. A., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.063149 · Cited by 86
Webster, G. R., Teh, A. Y., & K‐C., J. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26183 · Cited by 86
mitoTev‐TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels
Pereira, C. V., Bacman, S. R., Arguello, T., Zekonyte, U., Williams, S. L., Edgell, D. R., & Moraes, C. T. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708084 · Cited by 85
In Vivo Complementation of Complex I by the Yeast Ndi1 Enzyme
Seo, B. B., Nakamaru‐Ogiso, E., Flotte, T. R., Matsuno‐Yagi, A., & Yagi, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600922200 · Cited by 83
Bietenhader, M., Martos, A. A. R., Tétaud, E., Aiyar, R. S., Sellem, C. H., Kucharczyk, R., Clauder‐Münster, S., Giraud, M., Godard, F., Salin, B., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002876 · Cited by 77
Mitochondrial DNA mutations in the pathogenesis of human disease
Chinnery, P. F., & Turnbull, D. M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01805-0 · Cited by 75
Parkinson’s disease and mitochondrial complex I: a perspective on the Ndi1 therapy
Marella, M., Seo, B. B., Yagi, T., & Matsuno‐Yagi, A. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9249-z · Cited by 68
Ojaimi, J., Pan, J., Santra, S., Snell, W. J., & Schon, E. A. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-05-0306 · Cited by 65
Parkin modulates heteroplasmy of truncated mtDNA in Caenorhabditis elegans
Valenci, I., Yonai, L., Bar-Yaacov, D., Mishmar, D., & Ben‐Zvi, A. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.11.001 · Cited by 58
Gearing, D. P., & Nagley, P. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04695.x · Cited by 57
Early complex I assembly defects result in rapid turnover of the ND1 subunit
Rendón, O. Z., & Shoubridge, E. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds209 · Cited by 57
Schröder, T., Kucharczyk, D., Bär, F., Pagel, R., Derer, S., Jendrek, S. T., Sünderhauf, A., Brethack, A.-K., Hirose, M., Möller, S., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.010 · Cited by 57
Lim, S. C., Hroudová, J., Van Bergen, N. J., Sanchez, M. I. G. L., Trounce, I. A., & McKenzie, M. (2016) · The FASEB Journal · doi:10.1096/fj.201500137r · Cited by 57
Tachibana, M., Kuno, T., & Yaegashi, N. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12230 · Cited by 57
Prevalence and progression of mitochondrial diseases: A study of 50 patients
Arpa, J., Cruz-Martínez, A., Campos, Y., Gutiérrez-Molina, M., Rio, F. G., Pérez‐Conde, C., Martín, M. A., Rubio‐Terres, C., del Hoyo, P., Fernández, A. A., et al. (2003) · Muscle & Nerve · doi:10.1002/mus.10507 · Cited by 54
Galanis, M., Devenish, R. J., & Nagley, P. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80529-c · Cited by 54
Weiss, H., Wester-Rosenloef, L., Koch, C., Koch, F., Baltrusch, S., Tiedge, M., & Ibrahim, S. (2012) · Endocrinology · doi:10.1210/en.2012-1296 · Cited by 52
Chin, R. M., Panavas, T., Brown, J. M., & Johnson, K. K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.059 · Cited by 50 · cited 1×
“to improve protein import [39–42], utilization of specific upstream and downstream noncoding sequences [43–48], systematic testing of targeting sequence efficiencies [49,50], transkingdom expression [51–59] or piecewise import of proteins [38,60].”
BackgroundA single mutation in the first transmembrane domain of yeast COX2 enables its allotopic expression
Supeková, Ľ., Supek, F., Greer, J. E., & Schultz, P. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000735107 · Cited by 49
Inouye, S., Sahara-Miura, Y., Sato, J.-I., & Suzuki, T. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2015.02.002 · Cited by 49
Yu, X., Wester-Rosenlöf, L., Gimsa, U., Holzhueter, S.-A., Marques, A., Jonas, L., Hagenow, K., Kunz, M., Nizze, H., Tiedge, M., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp432 · Cited by 47
Yagi, T., Seo, B. B., Nakamaru‐Ogiso, E., Marella, M., Barber‐Singh, J., Yamashita, T., Kao, M., & Matsuno‐Yagi, A. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.191 · Cited by 45
Nagley, P., & Devenish, R. J. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90087-x · Cited by 45
Stachyra, A., Redkiewicz, P., Kosson, P., Protasiuk, A., Góra-Sochacka, A., Kudla, G., & Sirko, A. (2016) · Virology Journal · doi:10.1186/s12985-016-0599-y · Cited by 42
Bokori‐Brown, M., & Holt, I. J. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.455 · Cited by 41
Law, R. H. P., Farrell, L. B., Nero, D., Devenish, R. J., & Nagley, P. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80086-3 · Cited by 40
Reprogrammed expression of subunit 9 of the mitochondrial ATPase complex of Saccharomyces cerevisiae
Farrell, L. B., Gearing, D. P., & Nagley, P. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13976.x · Cited by 37
Analysis of mitochondrial ND1 gene in human colorectal cancer.
Akouchekian, M., Houshmand, M., Akbari, M., Kamalıdehghan, B., & Dehghan, M. (2011) · PubMed Central · Cited by 35
Mitochondrial genome inheritance and replacement in the human germline
Wolf, D. P., Hayama, T., & Mitalipov, S. M. (2017) · The EMBO Journal · doi:10.15252/embj.201797606 · Cited by 34
Mitochondrial tRNA(Thr) mutations and lethal infantile mitochondrial myopathy.
Brown, Torroni, A., Shoffner, J. M., & Wallace, D. C. (1992) · PubMed · Cited by 30
Stable nuclear expression of ATP8 and ATP6 genes rescues a mtDNA Complex V null mutant
Boominathan, A., Vanhoozer, S., Basisty, N., Powers, K., Crampton, A. L., Wang, X., Friedricks, N., Schilling, B., Brand, M. D., & O'Connor, M. S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw756 · Cited by 27
Self-citationRoucou, X., Artika, I. M., Devenish, R. J., & Nagley, P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00289.x · Cited by 23
Lu, Y., Zhao, D., Yao, S., Wu, S., Hong, D., Wang, Q., Liu, J., Smeitink, J. A. M., Yuan, Y., & Wang, Z. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.05.056 · Cited by 23
No Immune Responses by the Expression of the Yeast Ndi1 Protein in Rats
Marella, M., Seo, B. B., Flotte, T. R., Matsuno‐Yagi, A., & Yagi, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025910 · Cited by 22
Margulis, L. (1970) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(70)80023-6 · Cited by 20
González‐Halphen, D., Funes, S., Pérez-Martı́nez, X., Reyes‐Prieto, A., Claros, M. G., Davidson, E., & King, M. P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.039 · Cited by 17
Chemical synthesis of a mitochondrial gene designed for expression in the yeast nucleus.
Gearing, D. P., McMullen, G. L., & NAGLEY, P. (1985) · PubMed · Cited by 17
Iommarini, L., Ghelli, A., Tropeano, C., Kurelac, I., Leone, G., Vidoni, S., Lombes, A., Zeviani, M., Gasparre, G., & Porcelli, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030764 · Cited by 16
Eipel, C., Hildebrandt, A., Scholz, B., Schyschka, L., Minor, T., Kreikemeyer, B., Ibrahim, S. M., & Vollmar, B. (2011) · Life Sciences · doi:10.1016/j.lfs.2010.12.011 · Cited by 15
Rubalcava-Gracia, D., Vázquez‐Acevedo, M., Funes, S., Pérez-Martı́nez, X., & González‐Halphen, D. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-09-0560 · Cited by 13
McKenzie, M., Chiotis, M., Hroudová, J., Lopez Sanchez, M. I. G., Lim, S. C., Cook, M. J., McKelvie, P., Cotton, R. G. H., Murphy, M., St John, J. C., et al. (2014) · Human Mutation · doi:10.1002/humu.22694 · Cited by 12
Cruz-Torres, V., Vázquez‐Acevedo, M., García-Villegas, R., Pérez-Martı́nez, X., Mendoza‐Hernández, G., & González‐Halphen, D. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.09.006 · Cited by 11
Law, R. H. P., & Nagley, P. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90077-2 · Cited by 5
Flagged first, then by citations
2 of the 98 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mitochondrial diseases: from molecular mechanisms to therapeutic advances
Wen, H., Deng, H., Li, B., Chen, J., Zhu, J., Zhang, X., Yoshida, S., & Zhou, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02044-3 · Cited by 270
Li, Y., Zhu, L., Cai, M.-X., Wang, Z., Zhuang, M., Tan, C., Xie, T., Yao, Y., & Wei, T. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06111-5 · Cited by 88
Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges
Falabella, M., Minczuk, M. A., Hanna, M. G., Viscomi, C. F., & Pitceathly, R. D. S. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00715-9 · Cited by 42
Dotto, V. D., Musiani, F., Baracca, A., & Solaini, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042239 · Cited by 40
Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
Prasuhn, J., & Brüggemann, N. (2021) · Genes · doi:10.3390/genes12111840 · Cited by 34
Immuno-informatics guided designing of a multi-epitope vaccine against Dengue and Zika
Bhardwaj, A., Sharma, R., & Grover, A. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2002720 · Cited by 28
Rapid enrichment of mitochondria from mammalian cell cultures using digitonin
Dixit, B., Vanhoozer, S., Anti, N. A. O., O’Connor, M. S., & Boominathan, A. (2020) · MethodsX · doi:10.1016/j.mex.2020.101197 · Cited by 20
Self-citationThe Present and Future of Mitochondrial-Based Therapeutics for Eye Disease
Ji, M. H., Kreymerman, A., Belle, K. C., Ghiam, B. K., Muscat, S. P., Mahajan, V. B., Enns, G. M., Mercola, M. A., & Wood, E. H. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.8.4 · Cited by 18
Wang, J., Ji, Y., Ai, C., Chen, J., Gan, D., Zhang, J., Mo, J. Q., & Guan, M. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00951-1 · Cited by 17
The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics
Saravanan, S., Lewis, C. J., Dixit, B., O’Connor, M. S., Stolzing, A., & Boominathan, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020490 · Cited by 13
Self-citationThe constraints of allotopic expression
Nieto-Panqueva, F., Rubalcava-Gracia, D., Hamel, P. P., & González‐Halphen, D. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.09.004 · Cited by 9
Deciphering Codon Usage Patterns in the Mitochondrial Genome of the Oryza Species
Zhang, Y., Ma, Y., Yu, H., Han, Y., & Yu, T. (2024) · Agronomy · doi:10.3390/agronomy14112722 · Cited by 7
Advancing vaccine development in genomic era: a paradigm shift in vaccine discovery
Din, M. U., Liu, X., Jiang, H., Ahmad, S., Lai, X., & Wang, X. (2025) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/adb2c8 · Cited by 6
Exogenous expression of ATP8, a mitochondrial encoded protein, from the nucleus in vivo
Begelman, D. V., Dixit, B., Truong, C., King, C. D., Watson, M. A., Schilling, B., Brand, M. D., & Boominathan, A. (2024) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2024.101372 · Cited by 5
Self-citationLyu, L., Beibei, Q. I. E., He, Y., Chen, F., & Liu, B. C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07420-3 · Cited by 4
Wang, H., Lu, J., Henchy, C., Mullett, S. J., Richert, A. C., Goetzman, E. S., Toksoz, A., Hale, L., Wang, B. B., Mnatsakanyan, N., et al. (2026) · iScience · doi:10.1016/j.isci.2026.114889 · Cited by 3
Gene Therapy Tools for Diseases Caused by Mutations of the Mitochondrial Genome
Simonov, V., & Rastorguev, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125517 · Cited by 2
Emerging therapeutic strategies for mitochondrial DNA-related diseases
Shi, R., Falabella, M., Aref, J., Hanna, M. G., Minczuk, M. A., Viscomi, C. F., & Pitceathly, R. D. S. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102841
MitoSeqGen: a constrained generative transformer for mammalian mitochondrial mRNA codon optimizationPreprint
Bonthada, S. K. (2026) · Research Square · doi:10.21203/rs.3.rs-10901669/v1
Wang, H., Li, S., Wu, L., Shen, J., Li, X., Fu, K., Zou, H., Zhang, B., Qin, Y., Zeng, Y., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10903002/v1
Metadata
- Authors
- Lewis, C. J., Dixit, B., Batiuk, E., Hall, C. J., O'Connor, M. S., & Boominathan, A.
- Affiliations
- SENS Research Foundation (US)
- Corresponding author
- Boominathan, Amutha
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 30
- Pages
- 101429
- ISSN
- 2213-2317 (ISSN-L)
- PMC
- PMC6976934
- OpenAlex
- W2999808833
- Semantic Scholar
- 94aa834977c9f4466ebd67dd70e1cc2af4ad93ab
- Cited by
- 20
- References
- 98
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 1
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Redox Biology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- SENS Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- codon optimization, allotopic expression, mitochondrial DNA, mitochondrial disease, gene therapy, mitochondrial protein localization, ATP8, ND1, mitochondrial myopathy
- MeSH terms
- Codon Usage, Animals, DNA, Mitochondrial, Humans, Mitochondria, Models, Biological, Mutation, NADH Dehydrogenase, Gene Expression, Computational Biology, Mitochondrial Proteins, Mitochondrial Proton-Translocating ATPases, Mitochondrial Diseases, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review